Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | +1.33% | +1.33% | +3.40% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Other languages